Trials / Completed
CompletedNCT01644305
Plasma Levels of GDF-9 and GDF-15 in Patients With Polycystic Ovary Syndrome.
1. Association of Plasma GDF-9 or GDF-15 Levels With Bone Parameters in Polycystic Ovary Syndrome. 2. Plasma GDF-15 Levels and Their Association With Hormonal and Metabolic Status in Women With Polycystic Ovary Syndrome Aged 25-35.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 85 (actual)
- Sponsor
- Ankara Education and Research Hospital · Other Government
- Sex
- Female
- Age
- 25 Years – 35 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to determine the plasma levels of GDF-9 and GDF-15, and their association with bone and cardiovascular parameters in patients with Polycystic Ovary Syndrome.
Conditions
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2013-07-01
- Completion
- 2013-08-01
- First posted
- 2012-07-19
- Last updated
- 2018-06-27
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT01644305. Inclusion in this directory is not an endorsement.